iSpecimen (ISPC) Net Equity Issued and Repurchased (2021 - 2025)

iSpecimen's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $2.2 million for Q4 2025.

• In Q4 2025, Net Equity Issued and Repurchased rose 305.26% year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.9 million (up 629.02% YoY), while the FY2025 annual figure was $4.0 million, up 903.8% from the prior year.
• Net Equity Issued and Repurchased for Q4 2025 stood at $2.2 million, up from $1.8 million in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $2.2 million in Q4 2025, with the low at -$15.5 million in Q3 2021.
• The 3-year median for Net Equity Issued and Repurchased is $747207.0 (2024), against an average of -$1.9 million.
• Peak annual rise in Net Equity Issued and Repurchased reached 305.26% in 2025, while the deepest fall reached 305.26% in 2025.
• iSpecimen's Net Equity Issued and Repurchased stood at -$15.5 million in 2021, then jumped by 92.93% to -$1.1 million in 2024, then surged by 305.26% to $2.2 million in 2025.
• Business Quant data shows ISPC's Net Equity Issued and Repurchased at $2.2 million in Q4 2025, $1.8 million in Q3 2025, and -$1.1 million in Q4 2024.